CompuMed, Inc.
CMPD · OTC
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Revenue | $6 | $6 | $6 | $6 |
| % Growth | 6.6% | -8.3% | 0.8% | – |
| Cost of Goods Sold | $3 | $3 | $3 | $3 |
| Gross Profit | $3 | $3 | $3 | $3 |
| % Margin | 48.6% | 49.4% | 51.9% | 53% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $3 | $3 | $3 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3 | $3 | $3 | $2 |
| Operating Income | $0 | -$0 | $1 | $1 |
| % Margin | 3.3% | -0.5% | 8.6% | 16% |
| Other Income/Exp. Net | -$0 | $0 | -$0 | $0 |
| Pre-Tax Income | $0 | -$0 | $1 | $1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $0 | -$0 | $1 | $1 |
| % Margin | 3.1% | -0.6% | 7.9% | 16.9% |
| EPS | 0.15 | -0.021 | 0.3 | 0.69 |
| % Growth | 817.7% | -107% | -56.5% | – |
| EPS Diluted | 0.15 | -0.021 | 0.3 | 0.69 |
| Weighted Avg Shares Out | 1 | 2 | 2 | 2 |
| Weighted Avg Shares Out Dil | 1 | 2 | 2 | 2 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 | $0 |
| EBITDA | $1 | $1 | $1 | $1 |
| % Margin | 15.3% | 11.8% | 17.6% | 23.4% |